Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | +1.34% |
|
-8.48% | +155.93% |
05-21 | DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis | CI |
05-21 | Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+155.93% | 46.25M | |
+15.19% | 122B | |
+19.91% | 113B | |
+8.24% | 22.84B | |
-19.80% | 20.72B | |
-16.19% | 16.51B | |
-13.45% | 16.39B | |
-44.35% | 15.83B | |
+2.13% | 13.49B | |
+66.67% | 11.67B |
- Stock Market
- Equities
- DRRX Stock
- News DURECT Corporation
- Top Premarket Decliners